Literature DB >> 25247460

Utility of the test of memory malingering (TOMM) in children ages 4-7 years with and without ADHD.

Heather E Schneider1, John W Kirk, E Mark Mahone.   

Abstract

There is growing consensus that assessment for non-credible performance is a necessary component of pediatric neuropsychological examination. The current study examined the utility and validity of the Test of Memory Malingering (TOMM) in children ages 4-7 years with and without Attention-deficit/Hyperactivity Disorder (ADHD); 66 children (30 controls, 36 ADHD) completed all three TOMM trials. There were no significant group differences in total score on any trial, or passing rate for Trial 2 or Retention. Four-year-olds with ADHD achieved "passing" score on Trial 1 less often than controls. Across groups, performance on Trial 2 and Retention improved with age, such that 85% of the sample achieved a passing score. Four-year-olds had greater difficulty and achieved a passing score significantly less often than children 5-7 years. Moreover, half of the 4-year-olds performed worse on Retention than Trial 2, calling into question the utility of the Retention trial at this age. Performance was associated with IQ only within the ADHD group on the Retention trial. Results suggest that the TOMM can be used with confidence in clinical groups as young as 5 years. Among 4-year-olds, performance appears dependent on severity of ADHD or disruptive behaviors, and may be associated with factors other than effort.

Entities:  

Keywords:  Assessment; Childhood; Development; Neuropsychological.; Symptom validity

Mesh:

Year:  2014        PMID: 25247460      PMCID: PMC4208967          DOI: 10.1080/13854046.2014.960004

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  30 in total

Review 1.  Diagnostic criteria for malingered neurocognitive dysfunction: proposed standards for clinical practice and research.

Authors:  D J Slick; E M Sherman; G L Iverson
Journal:  Clin Neuropsychol       Date:  1999-11       Impact factor: 3.535

2.  Performance on the test of memory malingering in a mixed pediatric sample.

Authors:  Jacobus Donders
Journal:  Child Neuropsychol       Date:  2005-04       Impact factor: 2.500

3.  Assessment instruments measuring malingering used with individuals who have mental retardation: potential problems and issues.

Authors:  Kolleen E Hurley; William Paul Deal
Journal:  Ment Retard       Date:  2006-04

4.  Test of memory malingering (TOMM) trial 1 as a screening measure for insufficient effort.

Authors:  Sid E O'Bryant; Lisa R Engel; Jennifer S Kleiner; Jennifer J Vasterling; F William Black
Journal:  Clin Neuropsychol       Date:  2007-05       Impact factor: 3.535

5.  The value of the wechsler intelligence scale for children-fourth edition digit span as an embedded measure of effort: an investigation into children with dual diagnoses.

Authors:  Ashlee R Loughan; Robert Perna; Jeremy Hertza
Journal:  Arch Clin Neuropsychol       Date:  2012-09-12       Impact factor: 2.813

6.  The impact of cognitive and psychiatric impairment of psychotic disorders on the test of memory malingering (TOMM).

Authors:  Alexander Duncan
Journal:  Assessment       Date:  2005-06

7.  Clinical utility of Trial 1 of the Test of Memory Malingering (TOMM).

Authors:  Sid E O'Bryant; Brandon E Gavett; Robert J McCaffrey; Judith R O'Jile; Justin K Huerkamp; Todd A Smitherman; Joy D Humphreys
Journal:  Appl Neuropsychol       Date:  2008

Review 8.  Determination of effort level, exaggeration, and malingering in neurocognitive assessment.

Authors:  William J Lynch
Journal:  J Head Trauma Rehabil       Date:  2004 May-Jun       Impact factor: 2.710

9.  Performance of children on symptom validity tests: TOMM, MSVT, and FIT.

Authors:  Nina Blaskewitz; Thomas Merten; Norbert Kathmann
Journal:  Arch Clin Neuropsychol       Date:  2008-03-11       Impact factor: 2.813

10.  Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).

Authors:  Kelly Posner; Glenn A Melvin; Desiree W Murray; S Sonia Gugga; Prudence Fisher; Anne Skrobala; Charles Cunningham; Benedetto Vitiello; Howard B Abikoff; Jaswinder K Ghuman; Scott Kollins; Sharon B Wigal; Tim Wigal; James T McCracken; James J McGough; Elizabeth Kastelic; Roy Boorady; Mark Davies; Shirley Z Chuang; James M Swanson; Mark A Riddle; Laurence L Greenhill
Journal:  J Child Adolesc Psychopharmacol       Date:  2007-10       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.